FINWIRES · TerminalLIVE
FINWIRES

Top Midday Gainers

By

PN Smart Energy (PN) has completed its acquisition of the remaining 56.0% interest in Nanjing Cesun Power, advancing its transition toward becoming an independent power producer, the company said Thursday.

Shares soared 67% amid a surge in intraday trading volume to over 6.5 million from a daily average of about 1.9 million.

Columbus McKinnon (CMCO) delivered Q1 net sales growth of 125%, driven by the acquisition of Kito Crosby, the company said Thursday. It also increased its fiscal 2027 guidance.

Shares advanced 42% amid a rise in intraday trading volume to over 1.6 million from a daily average of roughly 569,000.

Digital Currency X Technology (DCX) signed a non-binding memorandum of understanding with Whales AI to bring STEM education robotics platform to the US and Canada

Shares jumped 14%, with intraday trading volume rising to more than 6.3 million, versus a daily average of about 758,000.

Price: $17.75, Change: $+7.03, Percent Change: +65.58%

Related Articles

Wire

Houlihan Lokey Fiscal Q1 Adjusted Earnings, Revenue Fall; Shares Drop After Hours

Houlihan Lokey (HLI) reported fiscal Q1 adjusted earnings late Wednesday of $1.35 per diluted share, down from $2.14 a year earlier.Analysts polled by FactSet expected $1.64.Revenue in the three months ended June 30 fell to $511 million from $605 million a year earlier.Analysts expected $602.4 million.Houlihan Lokey shares fell 6.6% in after-hours trading.

$HLI
Wire

Four Corners Property Trust Q2 AFFO, Revenue Rise

Four Corners Property Trust (FCPT) reported Q2 adjusted funds from operations late Wednesday of $0.45 per diluted share, up from $0.44 a year earlier.Analysts polled by FactSet expected $0.45.Revenue in the quarter ended June 30 rose to $78.4 million from $72.8 million a year earlier.Four analysts expected $79 million.The company's shares rose 2% in after-hours trading.

$FCPT
Wire

Corcept Therapeutics Q2 Earnings, Revenue Rise; Shares Jump After Hours

Corcept Therapeutics (CORT) reported Q2 earnings late Wednesday of $0.36 per diluted share, up from $0.29 a year earlier.Analysts polled by FactSet expected $0.02.Revenue for the three months ended June 30 rose to $256.1 million from $194.4 million a year earlier.Analysts expected $221.1 million.The company boosted full-year revenue guidance to $1.1 billion to $1.2 billion from the prior forecast of $950 million to $1.05 billion.Analysts project $999.5 million.Corcept shares jumped 18% in after-hours trading.

$CORT